METHYLDOPA IN HYPERTENSION CLINICAL AND PHARMACOLOGICAL STUDIES
- 14 April 1962
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 279 (7233), 759-763
- https://doi.org/10.1016/s0140-6736(62)91781-6
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Use of Alpha-Methyl-Dopa (Alpha-Methyl-3,4-Dihydroxy-DL-Phenylalanine) in the Management of the Carcinoid SyndromeNew England Journal of Medicine, 1961
- CLINICAL AND PHARMACOLOGICAL STUDIES WITH GUANETHIDINE IN THE TREATMENT OF HYPERTENSIONThe Lancet, 1960
- Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanineScience, 1960
- Hemmung der Serotoninbildung durch ?-Methyl-DopaNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1958
- Inhibition of dihydroxyphenylalanine decarboxylase by derivatives of phenylalanineArchives of Biochemistry and Biophysics, 1954